TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April

Bulletin Express

04/27

Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.

In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.

The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1184590339"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184590339\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184590339?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184590339","market":"us","top_or_hot":-1,"title":"TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April","media":"Bulletin Express","content":"<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.</p>\n<p>In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-27 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.</p>\n<p>In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03613","symbol_name":"同仁堂国药","start_time":0,"source_url":"","article_id":"1184590339","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184590339","pubTimestamp":1777283036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03613":"同仁堂国药"},"translate_title":"同仁堂CM重点公布同仁堂科技2026年第一季度未经审计业绩；母公司将于4月30日前披露数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":1},"content_text":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.\nIn addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.\nThe board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}